BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 30771783)

  • 21. Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
    Mashiach E; Alzate JD; De Nigris Vasconcellos F; Adams S; Santhumayor B; Meng Y; Schnurman Z; Donahue BR; Bernstein K; Orillac C; Bollam R; Kwa MJ; Meyers M; Oratz R; Novik Y; Silverman JS; Harter DH; Golfinos JG; Kondziolka D
    J Neurooncol; 2024 May; 168(1):99-109. PubMed ID: 38630386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria.
    Serizawa T; Hirai T; Nagano O; Higuchi Y; Matsuda S; Ono J; Saeki N
    J Neurooncol; 2010 Jun; 98(2):163-7. PubMed ID: 20411300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity.
    Diao K; Bian SX; Routman DM; Yu C; Ye JC; Wagle NA; Wong MK; Zada G; Chang EL
    J Neurooncol; 2018 Sep; 139(2):421-429. PubMed ID: 29696531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.
    Chao ST; Barnett GH; Vogelbaum MA; Angelov L; Weil RJ; Neyman G; Reuther AM; Suh JH
    Cancer; 2008 Oct; 113(8):2198-204. PubMed ID: 18780319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiosurgery combined with anlotinib for limited brain metastases with perilesional edema in non-small cell lung cancer: Rvision-001 study protocol.
    Wang Y; Wang X; Guan Y; Song Y; Zhuang H; Wang E
    Thorac Cancer; 2020 May; 11(5):1361-1364. PubMed ID: 32163662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis.
    Yomo S; Oda K; Oguchi K
    J Neurosurg; 2023 Dec; 139(6):1628-1637. PubMed ID: 37243558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC.
    Krämer AS; Adeberg S; Kronsteiner D; König L; Schunn F; Bozorgmehr F; Christopoulos P; Eichkorn T; Schiele A; Hahnemann L; Rieken S; Debus J; Shafie RAE
    Clin Lung Cancer; 2023 May; 24(3):269-277. PubMed ID: 36803615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain Metastases.
    Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.
    Kiess AP; Wolchok JD; Barker CA; Postow MA; Tabar V; Huse JT; Chan TA; Yamada Y; Beal K
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):368-75. PubMed ID: 25754629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical center.
    Chen YC; Yang HC; Chiang CL; Chen CJ; Shen CI; Wu HM; Luo YH; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Hung-Chi Pan D; Lee CC
    J Neurooncol; 2023 Jan; 161(1):135-146. PubMed ID: 36469189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
    Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Werner-Wasik M; Demas W; Ryu J; Bahary JP; Souhami L; Rotman M; Mehta MP; Curran WJ
    Lancet; 2004 May; 363(9422):1665-72. PubMed ID: 15158627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic radiosurgery plus whole-brain radiotherapy.
    Nieder C; Nestle U; Walter K; Niewald M; Schnabel K
    Am J Clin Oncol; 2000 Dec; 23(6):584-8. PubMed ID: 11202802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non-small cell lung cancer and brain metastases.
    Lee CC; Hsu SPC; Lin CJ; Wu HM; Chen YW; Luo YH; Chiang CL; Hu YS; Chung WY; Shiau CY; Guo WY; Hung-Chi Pan D; Yang HC
    J Neurosurg; 2019 Jun; ():1-8. PubMed ID: 31226692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Session Gamma Knife Radiosurgery for Patients With 20 or More Brain Metastases.
    Wei Z; Luy DD; Jose S; Deng H; Yavan S; Worrell S; Belkhir JR; Tang LW; Niranjan A; Lunsford LD
    Neurosurgery; 2023 Oct; 93(4):857-866. PubMed ID: 37018427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers.
    Bernad DM; Sperduto PW; Souhami L; Jensen AW; Roberge D
    J Neurooncol; 2010 Jun; 98(2):249-52. PubMed ID: 20376550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm.
    Prabhu RS; Miller KR; Asher AL; Heinzerling JH; Moeller BJ; Lankford SP; McCammon RJ; Fasola CE; Patel KR; Press RH; Sumrall AL; Ward MC; Burri SH
    J Neurosurg; 2018 Dec; ():1-8. PubMed ID: 30554174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-front single-session radiosurgery for large brain metastases-volumetric responses and outcomes.
    Benjamin C; Gurewitz J; Nakamura A; Mureb M; Mullen R; Pacione D; Silverman J; Kondziolka D
    Acta Neurochir (Wien); 2023 May; 165(5):1365-1378. PubMed ID: 36702970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term predictors of stereotactic radiosurgery outcome for untreated single non-small cell lung cancer brain metastases: a restrospective cohort study.
    Neto EB; de Almeida Bastos DC; Yoshikawa MH; Figueiredo EG; de Assis de Souza Filho F; Prabhu S
    Neurosurg Rev; 2024 Apr; 47(1):172. PubMed ID: 38639882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
    Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
    J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer.
    Wandrey NE; Gao D; Robin TP; Contessa JN; Singh C; Chiang V; Li J; Chen A; Wang Y; Sheehan JP; Dutta SW; Weiss SE; Paly J; Rusthoven CG
    Lung Cancer; 2023 Feb; 176():144-148. PubMed ID: 36641932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.